Modelling the economic impact of substandard and falsified medicines: the case of antimalarials in the democratic republic of congo

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: OZAWA, Sachiko (University of North Carolina at Chapel Hill, Practice Advancement and Clinical Education, Chapel Hill, United States)
  • Co-author(s): Sachiko Ozawa: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Sophia Bessias: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Deson Haynie: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Tatenda Yemeke: Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, United States
  • Abstract:

    Background

    Access to high-quality medicines is a critical element in reaching the Sustainable Development Goals (SDGs). Substandard and falsified medicines pose significant risks to global health, including increased deaths, prolonged treatment times and increased drug resistance. Antimalarial drugs, despite their importance in global health, are..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login